perimenopausal dry eyes
Conditions
Interventions
Sponsors
Eye Hospital China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Patients with dry eye. 2. Perimenopausal women who meet the syndrome of kidney deficiency and liver stagnation. 3. Patients who are currently using artificial tears or anti-inflammatory eye drops should wait for one week after discontinuing the medication before being included. 4. Participants have signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with scleral scarring Sjogren's syndrome or severe meibomian glanditis. 2. Patients with glaucoma who require topical hypotensive medication to control intraocular pressure. 3. Perimenopausal women with emotional disorders or severe cardiovascular cerebrovascular or liver and kidney diseases with liver and kidney function exceeding normal values by 2 times or more. 4. Patients who have used sex hormones within the past 3 months. 5. Patients who are currently participating in other drug clinical trials or who are taking similar Chinese herbal medicines and other treatments. 6. Patients who do not wish to participate in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ocular Surface disease Index score;Tear film rupture time; | — |
Secondary
| Measure | Time frame |
|---|---|
| General Symptom Score;Corneal epithelial status;Ocular symptom score;Schirmer test;Estradiol (E2) follicle stimulating hormone (FSH) anti-Mullerian hormone (AMH) levels; | — |
Countries
China
Contacts
Public ContactLianrong Yin
Eye Hospital China Academy of Chinese Medical Sciences
Outcome results
None listed